LTS LOHMANN Therapie-Systeme AG Sustainability Reports
The company operates as a contract development and manufacturing organization (CDMO) specializing in transdermal therapeutic systems, oral thin films, and microneedle array patches for the pharmaceutical industry.
Sector: Manufacturing
Country: Germany
Exchange: Unlisted
LEI: 529900Z0OSVTBAO1IJ04
4 reports from 2024 to 2025
- LTS LOHMANN Therapie-Systeme AG 2025 Sustainability Report
- LTS LOHMANN Therapie-Systeme AG 2024 Declaration of Principle on Compliance with Human Rights and Environment-Related Due Diligence Obligations
- LTS LOHMANN Therapie-Systeme AG 2024 Supplier Code of Conduct
- LTS LOHMANN Therapie-Systeme AG 2024 Sustainability Report